Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more… Read More
Seattle-based biotech upstart Kineta announced a new investment partnership with RLB Holdings, a Connecticut-based investment firm that partially owns the… Read More
Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing… Read More
TaxACT co-founder Lance Dunn has been appointed to the board of Blucora, the search and tax preparation company formerly known as InfoSpace. Blucora purchased TaxACT… Read More
Another day, another executive departure from RealNetworks. Yesterday, we reported that chief financial officer Michael Eggers — a 14-year veteran… Read More
Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors… Read More
Big news today in Seattle’s biotech industry. Seattle biotechnology upstart Allozyne has entered into a merger agreement with San Francisco’s… Read More
Accelerator Corp. has backed its 12th startup, a cancer research company that’s attempting to disrupt signaling pathways between tumors and the… Read More
We’ve bemoaned the fact that very few Seattle area companies are considering initial public offerings. But Koronis Pharmaceuticals, a Seattle… Read More
